Evenity injection sites

injection site; rash at the injection site; swelling at the injection site; generalised muscle weakness. Dysport powder for injection is a white freeze

Most frequently reported terms (≥ 1%)were: Injection site reaction, Injection site erythema. Injection site pruritus, Injection site bruising, Injection site

Rare (0.01% to 0.1%): Injection site abscess, injection site cellulitis, injection site cyst, injection site hematoma drugs, over-the-counter

Rotate injection sites. If you ve been giving yourself injections, you know some sites are much less painful than others. Even though it s tempting to stick to these sites, rotating injection sites will decrease your risk of developing injection site reactions. Get medications to room temperature.

Rotate sites! Remember to rotate your injection sites. Routinely using the same sites (and even general areas) for your insulin injections will definitely cause bruising, and can even hasten the development of scar tissue, which can lead to malabsorption of insulin, leading to higher blood sugars.

Uncommon (0.1% to 1%): Injection site warmth; Rare (0.01% to 0.1%): Injection site discomfort; Postmarketing reports: Decreased injected limb mobility, injection site cellulitis-like reaction, injection site inflammation, injection site rash, injection site reaction, injection site sterile abscess, large injection site swelling ; Metabolic

Injection site reactions occurred in 8.2% of patients and included injection site reaction (3.1%), injection site pain (2.2%), injection site erythema (1.6%), and injection site rash (0.7%). These reactions were mild or moderate in severity, transient, and

Injection site reactionsa 18 13 a . Injection site reactions include multiple related adverse event terms, such as injection site pain, injection site reaction, injection site erythema, and injection site pruritus. 6.2 . Immunogenicity . As with all therapeutic proteins, there is potential for immunogenicity. The detection of antibody formation

reactions at the injection site reported 1% were: Injection site reaction, Injection site erythema, Injection site pruritus, Injection site bruising, Injection site swelling. The majority of events related to the injection site were mild to moderate and less than 0.5 %